ReviewThyroid research2026
Global and Indian perspectives on trimester-specific reference intervals for thyroid hormones in pregnant women: a systematic review.
Review in Thyroid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Establishment of trimester-specific reference intervals (RIs) for thyroid hormones is essential to avoid misdiagnosis and misinterpretation in pregnant women. This systematic review comprehensively analysed gestational age-specific reference intervals in different populations. The electronic databases such as Medline, Embase, Scopus, and Google Scholar were searched to identify relevant articles. The reference population, consisting of healthy pregnant women in the first, second, and third trimesters of pregnancy, meeting eligibility, such as the absence of thyroid disease, a negative thyroid peroxidase (TPO) antibody test, and sufficient urinary iodine concentration (UIC), was selected for the present study. Of the 1,160 studies identified in the databases, 48 were eligible for the systematic review. Data on trimester-specific RIs, established from a 95% confidence interval (CI) between the 2.5th percentile (lower limit) and the 97.5th percentile (upper limit) of thyroid hormones, were extracted. In most studies, the upper limit of TSH in healthy pregnant women during the first (85.4%), second (94.1%), and third trimesters (72%) was determined to be 2.15-4.51 mIU/L, 2.73-4.84 mIU/L, and 2.90-4.91 mIU/L, respectively. Furthermore, the lower and upper limits of FT4 during the first (80.5% and 87.8%), second (83.3% and 90%), and third trimesters (82.1% and 96.4%) have been reported as being between 10.17 and 14.16 pmol/L and 15.22-23.94 pmol/L, 8.31-11.71 pmol/L and 15.47-20.59 pmol/L, and 7.39-9.78 pmol/L and 12.03-19.82 pmol/L, respectively. The study results showed that reference value for thyroid hormones vary within the same population and also between different populations, particularly for TSH. Given this high variability, even within the Indian population, it is imperative to establish population-specific reference values.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.